BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38057895)

  • 1. Correlation between controlled ovarian stimulation protocols and euploid blastocyst rate in pre-implantation genetic testing for aneuploidy cycles.
    Huang B; Li H; Xu B; Li N; Wang X; Li Y; Zhao J
    Reprod Biol Endocrinol; 2023 Dec; 21(1):118. PubMed ID: 38057895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles.
    Vidal MDM; Martínez F; Rodríguez I; Polyzos NP
    Hum Reprod; 2024 May; 39(5):1098-1104. PubMed ID: 38498835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of blastocyst euploidy rates following luteal versus follicular phase stimulation in a GnRH antagonist protocol: a prospective study with repeated ovarian stimulation cycles.
    Martinez F; Clua E; Roca M; Garcia S; Polyzos NP
    Hum Reprod; 2022 Nov; 37(12):2777-2786. PubMed ID: 36269092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF.
    Pai AH; Sung YJ; Li CJ; Lin CY; Chang CL
    Reprod Biol Endocrinol; 2023 Aug; 21(1):72. PubMed ID: 37550681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation.
    La Marca A; Capuzzo M; Sacchi S; Imbrogno MG; Spinella F; Varricchio MT; Minasi MG; Greco P; Fiorentino F; Greco E
    Hum Reprod; 2020 Jun; 35(6):1325-1331. PubMed ID: 32395749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of euploidy rates in preimplantation genetic testing for aneuploidy cycles with progestin-primed versus GnRH agonist/antagonist protocol.
    Wang L; Wang J; Zhang Y; Qian C; Wang X; Bai J; Li F; Chen Z; Ai A
    Eur J Med Res; 2023 Jan; 28(1):28. PubMed ID: 36642707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.
    Cimadomo D; Capalbo A; Dovere L; Tacconi L; Soscia D; Giancani A; Scepi E; Maggiulli R; Vaiarelli A; Rienzi L; Ubaldi FM
    Hum Reprod; 2021 Mar; 36(4):929-940. PubMed ID: 33608730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Number of Euploid Embryos in Preimplantation Genetic Testing Cycles With Early-Follicular Phase Long-Acting Gonadotropin-Releasing Hormone Agonist Long Protocol.
    Li G; Wu Y; Niu W; Xu J; Hu L; Shi H; Sun Y
    Front Endocrinol (Lausanne); 2020; 11():424. PubMed ID: 32793112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations.
    Zhou R; Dong M; Huang L; Wang S; Fan L; Liang X; Zhang X; Liu F
    Front Endocrinol (Lausanne); 2023; 14():1117513. PubMed ID: 37143731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Euploidy rates among preimplantation genetic testing for aneuploidy cycles with oral dydrogesterone primed ovarian stimulation or GnRH antagonist protocol.
    Yang L; Luo K; Lu G; Lin G; Gong F
    Reprod Biomed Online; 2022 Oct; 45(4):721-726. PubMed ID: 35989167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ovarian stimulation on aneuploidy of early aborted tissues and preimplantation blastocysts: comparison of the GnRH agonist long protocol with the GnRH antagonist protocol.
    Wang J; Zhang J; Zhao N; Ma Y; Wang X; Gou X; Ju Y; Zhang H; Chen S; Wang X
    J Assist Reprod Genet; 2022 Aug; 39(8):1927-1936. PubMed ID: 35767166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the reproductive potential of day 7 euploid embryos?
    Hernandez-Nieto C; Lee JA; Slifkin R; Sandler B; Copperman AB; Flisser E
    Hum Reprod; 2019 Sep; 34(9):1697-1706. PubMed ID: 31398251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medroxyprogesterone acetate: an alternative to GnRH-antagonist in oocyte vitrification for social fertility preservation and preimplantation genetic testing for aneuploidy.
    Giles J; Cruz M; Cobo A; Vidal C; Requena A; Remohi J; Bosch E
    Reprod Biomed Online; 2023 Aug; 47(2):103222. PubMed ID: 37290978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle.
    Cimadomo D; Vaiarelli A; Colamaria S; Trabucco E; Alviggi C; Venturella R; Alviggi E; Carmelo R; Rienzi L; Ubaldi FM
    Hum Reprod; 2018 Aug; 33(8):1442-1448. PubMed ID: 29912374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an artificial intelligence model for predicting the likelihood of human embryo euploidy based on blastocyst images from multiple imaging systems during IVF.
    Diakiw SM; Hall JMM; VerMilyea MD; Amin J; Aizpurua J; Giardini L; Briones YG; Lim AYX; Dakka MA; Nguyen TV; Perugini D; Perugini M
    Hum Reprod; 2022 Jul; 37(8):1746-1759. PubMed ID: 35674312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oocyte competence is comparable between progestin primed ovarian stimulation with Norethisterone acetate (NETA-PPOS) and GnRH-antagonist protocols: A matched case-control study in PGT-A cycles.
    Vaiarelli A; Cimadomo D; Ruffa A; Rania E; Pittana E; Gallo C; Fiorenza A; Alviggi E; Alfano S; Carmelo R; Trabucco E; Alviggi C; Rosaria Campitiello M; Rienzi L; Maria Ubaldi F; Venturella R
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():4-10. PubMed ID: 38171151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worth the wait? Day 7 blastocysts have lower euploidy rates but similar sustained implantation rates as Day 5 and Day 6 blastocysts.
    Tiegs AW; Sun L; Patounakis G; Scott RT
    Hum Reprod; 2019 Sep; 34(9):1632-1639. PubMed ID: 31402381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparision among euploidy of preimplantation blastocysts in different controlled ovary stimulation (COH) protocols.
    Wang Y; Xu J; Yin X; Fang Y; Li K
    Arch Gynecol Obstet; 2024 May; ():. PubMed ID: 38713294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts.
    Capalbo A; Rienzi L; Cimadomo D; Maggiulli R; Elliott T; Wright G; Nagy ZP; Ubaldi FM
    Hum Reprod; 2014 Jun; 29(6):1173-81. PubMed ID: 24578475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing blastocyst euploid rates between the progestin-primed and gonadotrophin-releasing hormone antagonist protocols in aneuploidy genetic testing: a randomised trial protocol.
    Li H; Yu M; Zhang W; Chen J; Chen H; Lu X; Li L; Ng EHY; Sun X
    BMJ Open; 2024 Mar; 14(3):e079208. PubMed ID: 38521533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.